PATENT CLAIM ANALYSIS

Application Number: 15916371
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "769000"]

Abstract:
A solid pharmaceutical composition suitable for oral administration, comprising: (a) a S1P receptor modulator; (b) a filler, and (c) a cyclodextrin.

Claim (Index 6):
The composition according to  claim 1 , wherein the first compound is 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14009241', '12189323', '14842517', '11198710', '14435346']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7161317905620361
- 35 USC 102 Novelty (BERT): 0.5319737708806428
- Combined Prediction Score: 0.6977159885938968
- Mean Citation Score: 191.739828
- Max Citation Score: 344.9039
- Similarity Product: 343.0360937597752

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test